Try our Advanced Search for more refined results

ERFINDERGEMEINSCHAFT UROPEP GbR v. Eli Lilly and Company et al

  1. August 28, 2017

    Lilly Loses Bid To Escape $20M Cialis Patent Verdict

    Eli Lilly & Co. on Friday lost a post-trial attempt to invalidate a German pharmaceutical company's patent when a Texas federal court denied a motion for judgment or a new trial, leaving Lilly to pay $20 million for infringing the patent when marketing the erectile dysfunction drug Cialis to treat enlarged prostates.

  2. June 15, 2017

    Lilly Says Atty Fees Uncalled For After $20M Patent Loss

    Eli Lilly and Co. fought back Wednesday against an attempt by a German drugmaker to pin its legal bill on Lilly after winning a $20 million patent verdict, saying that attorneys' fees are added to judgments only in "exceptional" cases and that this one was anything but.

  3. June 02, 2017

    German Co. Seeks Attys' Fees In $20M Cialis IP Trial

    A German pharmaceutical company told a Texas federal court Thursday that Eli Lilly and Co. pursued frivolous arguments in a patent trial over new uses for the erectile dysfunction drug Cialis, urging the judge to add attorneys' fees to the $20 million verdict.

  4. May 23, 2017

    Lilly's $20M Cialis Patent Verdict Stayed During Appeal

    A Texas federal judge on Tuesday stayed a $20 million judgment against Eli Lilly & Co. while the drugmaker appeals to the Federal Circuit the jury's finding that Lilly infringed a German pharmaceutical company's patent when marketing a new use of the erectile dysfunction drug Cialis.

  5. May 18, 2017

    Lilly Ordered To Pay Jury's $20M Cialis Patent Verdict

    A Texas federal judge on Thursday entered a $20 million judgment against Eli Lilly & Co. for infringing a German pharmaceutical company's patent and then broke down his reasoning for various midtrial decisions, including why he found Lilly's infringement wasn't willful.

  6. April 24, 2017

    Lilly Hit With $20M Jury Verdict In Cialis Patent Row

    Eli Lilly & Co. infringed a German pharmaceutical company’s patent when marketing the erectile dysfunction drug Cialis to treat enlarged prostates and should hand over $20 million in damages, a Texas federal jury has found.

  7. March 15, 2017

    'Presumption Of Validity' Barred From Cialis Patent Trial

    A federal judge in Texas has barred the phrase “presumption of validity” from an upcoming patent infringement trial over Eli Lilly and Co.’s erectile dysfunction drug Cialis, saying the wording could trip up the jury.

  8. March 08, 2017

    Lilly Denied Quick Win On Willful Infringement Under Halo

    Eli Lilly and Co. was recently denied a quick ruling on whether it willfully infringed a patent covering enlarged-prostate treatments by selling erectile dysfunction drug Cialis, with the Eastern District of Texas saying Lilly failed to meet the Halo standard for overcoming the claim.

  9. February 26, 2016

    Fish & Richardson Escapes DQ Bid In Cialis Patent Row

    Fish & Richardson PC can represent a German pharmaceutical company in a patent suit over Cialis against a former client and Eli Lilly & Co., a Texas federal judge ruled Friday, saying the similarities between the earlier case and the instant suit are "meaningless."

  10. August 25, 2015

    Eli Lilly's IP Suit Defense Based On Typo, Pharma Co. Says

    A German pharmaceutical company suing Eli Lilly and Co. for alleged patent infringement fired back in Texas federal court Monday, saying claims it doesn't own the patent are based on a typographical error that has persisted for nearly a decade and was corrected before the suit was filed.